TABLE 1.
Strainb | MIC (mg/liter) of drug: |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
CPT |
DAP |
CFZ |
RIF |
VAN |
||||||
BMD | Biofilm | BMD | Biofilm | BMD | Biofilm | BMD | Biofilm | BMD | Biofilm | |
6242 | 1 | 2 | 0.25 | 8 | 16 | >64 | <0.0625 | >64 | 0.5 | 8 |
6246 | 1 | 2 | 0.125 | 2 | >64 | >64 | <0.0625 | >64 | 1 | 2 |
6911* | 1 | 2 | 2 | 4 | >64 | >64 | >32 | >64 | 2 | 8 |
5657 | 1 | 2 | 0.125 | 4 | >64 | >64 | <0.0625 | >64 | 1 | 8 |
5253 | 1 | 1 | 1 | 8 | 32 | >64 | <0.0625 | >64 | 2 | 16 |
5255 | 1 | 2 | 0.125 | 8 | 16 | >64 | <0.0625 | >64 | 0.5 | 16 |
5849* | 1 | 2 | 0.25 | 8 | 16 | >64 | <0.0625 | >64 | 0.5 | 8 |
5993 | 2 | 2 | 2 | 8 | 64 | >64 | >32 | >64 | 4 | 4 |
5995 | 0.5 | 0.5 | 4 | 16 | 64 | >64 | 0.5 | 64 | 4 | 32 |
5998 | 1 | 2 | 1 | 4 | >64 | >64 | 2 | >64 | 4 | 8 |
6000 | 0.25 | 0.5 | 4 | 8 | 32 | >64 | 8 | >64 | 4 | 16 |
6012* | 1 | 1 | 0.25 | 2 | 64 | >64 | <0.0625 | 2 | 0.5 | 2 |
6067* | 0.5 | 0.5 | 4 | 16 | >64 | >64 | 4 | >64 | 2 | 4 |
6072* | 1 | 1 | 4 | 16 | 64 | >64 | 4 | 8 | 1 | 2 |
6184* | 0.5 | 1 | 0.5 | 4 | 16 | >64 | <0.0625 | 16 | 0.5 | 8 |
6212* | 2 | 2 | 2 | 2 | >64 | >64 | <0.0625 | 32 | 1 | 2 |
6232 | 1 | 2 | 0.5 | 8 | >64 | >64 | <0.0625 | >64 | 1 | 8 |
6235 | 2 | 2 | 0.125 | 8 | >64 | >64 | <0.0625 | >64 | 1 | 4 |
6240 | 0.5 | 2 | 0.25 | 8 | 16 | >64 | <0.0625 | >64 | 1 | 8 |
6299 | 0.25 | 0.25 | 0.5 | 2 | 16 | >64 | <0.0625 | >64 | 4 | 8 |
Abbreviations: CPT, ceftaroline; DAP, daptomycin; CFZ, cefazolin; RIF, rifampin; VAN, vancomycin.
All strain designations begin with “R.” Asterisks indicate isolates proven to be heterogeneous VISA by modified population analysis.